|
|
A J Manheimer-Lory, G Zandman-Goddard, A Davidson, C Aranow, B Diamond
J Clin Invest. 1997;
100(10):2538
doi:10.1172/JCI119796
Abstract |
Full text
| PDF

T
he F4 idiotype is a heavy chain determinant expressed almost exclusively on IgG immunoglobulins and is highly associated with specificity for double-stranded DNA. Since high-titered F4 expression is present predominantly in sera of patients with systemic lupus erythematosus (SLE), we thought F4+ IgG antibodies might constitute a useful subset of immunoglobulins in which to investigate lupus-specific alterations in variable (V) region gene expression or in the process of somatic mutation. This molecular analysis of F4+ B cell lines generated from lupus patients demonstrates that despite the strong association of F4 reactivity with specificity for native DNA, there is no apparent VH gene restriction. Furthermore, VH gene segments encoding these antibodies are also used in protective immune responses. An examination of the process of somatic mutation in F4+ antibodies showed no abnormality in frequency of somatic mutation nor in the distribution of mutations in complementarity-determining regions or framework regions. However, there was a decrease in targeting of mutations to putative mutational hot spots. This subtle difference in mutations present in these antibodies may reflect an intrinsic defect in mutational machinery or, more likely, altered state of B cell activation that affects the mutational process and perhaps also negative selection.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(19)
| Title and authors |
Publication |
Year |
Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis
Chuancang Jiang, Ming-Lang Zhao, Richard M. Scearce, Marilyn Diaz
|
Arthritis Rheum
|
2011 |
Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors.
Brun Mietzner, Makoto Tsuiji, Johannes Scheid, Klara Velinzon, Thomas Tiller, Klaus Abraham, Jose B Gonzalez, Virginia Pascual, Dorothee Stichweh, Hedda Wardemann, Michel C Nussenzweig
|
Proc. Natl. Acad. Sci. U.S.A.
|
2008 |
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.
Angela Lee Foreman, Judy Van de Water, Marie-Lise Gougeon, M Eric Gershwin
|
Autoimmunity Reviews
|
2007 |
Autoantibodies that bind glomeruli: Cross-reactivity with bacterial antigen
Iftikhar A. Chowdhry, Czeslawa Kowal, John Hardin, Zhijie Zhou, Betty Diamond
|
Arthritis Rheum
|
2005 |
Cross-reactivity of human lupus anti-DNA antibodies with ?-actinin and nephritogenic potential
Zeguo Zhao, Elena Weinstein, Marina Tuzova, Anne Davidson, Peter Mundel, Paola Marambio, Chaim Putterman
|
Arthritis Rheum
|
2005 |
B-cell biology
Elena Weinstein, Elena Peeva, Chaim Putterman, Betty Diamond
|
Rheumatic Disease Clinics of North America
|
2004 |
The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease
Brian P. O'Connor, Michael W. Gleeson, Randolph J. Noelle, Loren D. Erickson
|
Immunol Rev
|
2003 |
Aberrant Expression of the Costimulatory Molecule CD40 Ligand on Monocytes from Patients with Systemic Lupus Erythematosus
Christina G. Katsiari, Stamatis-Nick C. Liossis, Vassilis L. Souliotis, Athanasios M. Dimopoulos, Menelaos N. Manoussakis, Petros P. Sfikakis
|
Clinical Immunology
|
2002 |
Receptor Revision and Systemic Lupus
M. Monestier, M. Zouali
|
Scand J Immunol
|
2002 |
Immunoglobulin variable-region gene usage in systemic autoimmune diseases
Thomas D�rner, Peter E. Lipsky
|
Arthritis Rheum
|
2001 |
|